So How does Biel get to a $1-Share-Price witho
Post# of 7811
(Total Views: 428)
Posted On: 05/19/2019 3:48:10 PM
So How does Biel get to a $1-Share-Price
without a reverse split? Simple 15-25 Million users will do it.
Biel Share Price Per Each 1 Million Actipatches sold per year.
Estimated profit per Actipatch after all costs is $7.00
Think profit is half that, divide the following numbers by two. A third, divide the numbers by three.
20.1 Billion shares outstanding and 25 Billion Authorized. I will use a 25 Billion figure.
$7,000,000 divided by 25 Billion = $.00028 X PE =
PE 30 = $.0084
PE 60 = $.0168
PE 120 =$.0336
High growth companies can sport a much higher PE.
Those numbers are for just $7,000,000 profit in a Year or $1,750,000 profit per Quarter.
That is for 1,000,000 Actipatches sold per Year.
Keep in mind the average user uses 2.7 Actipatches a year,
and that number is expected to be 10.8 Actipatches per user a year in the U.K.,
with the Government of the U.K. paying for the Actipatches.
So do you think Biel will sell 10 Million Actipatches a Year? ABSOLUTELY YES.
Multiply those PE numbers by 10. --- Yes, that is $.084 to $.336 per share.
50 Million Actipatches a year?
Multiply those PE numbers by 50. --- Yes, that is $.42 to $1.68
100 Million Actipatches a Year?
Multiply those PE numbers by 100. --- Yes that is $.84 to $3.36
200 million Actipatches a year?
At this Point PE would not be over 60 in all probability, but never say never.
Multiply those PE numbers by 200. --- Yes that is $1.68 to $6.72
Adjust the numbers as you wish, this is a price predicting model based on sales.
There is NOTHING wrong with the share structure other then widely held false beliefs.
CLUE: NHS average user is predicted to use 10.8 Actipatches a year.
Just 100,000 users is 1,080,000 Actipatches purchased per year.
NHS is the Government of the U.K. which is PAYING for Actipatches for their
Estimated 25-29 Million pain sufferers.
without a reverse split? Simple 15-25 Million users will do it.
Biel Share Price Per Each 1 Million Actipatches sold per year.
Estimated profit per Actipatch after all costs is $7.00
Think profit is half that, divide the following numbers by two. A third, divide the numbers by three.
20.1 Billion shares outstanding and 25 Billion Authorized. I will use a 25 Billion figure.
$7,000,000 divided by 25 Billion = $.00028 X PE =
PE 30 = $.0084
PE 60 = $.0168
PE 120 =$.0336
High growth companies can sport a much higher PE.
Those numbers are for just $7,000,000 profit in a Year or $1,750,000 profit per Quarter.
That is for 1,000,000 Actipatches sold per Year.
Keep in mind the average user uses 2.7 Actipatches a year,
and that number is expected to be 10.8 Actipatches per user a year in the U.K.,
with the Government of the U.K. paying for the Actipatches.
So do you think Biel will sell 10 Million Actipatches a Year? ABSOLUTELY YES.
Multiply those PE numbers by 10. --- Yes, that is $.084 to $.336 per share.
50 Million Actipatches a year?
Multiply those PE numbers by 50. --- Yes, that is $.42 to $1.68
100 Million Actipatches a Year?
Multiply those PE numbers by 100. --- Yes that is $.84 to $3.36
200 million Actipatches a year?
At this Point PE would not be over 60 in all probability, but never say never.
Multiply those PE numbers by 200. --- Yes that is $1.68 to $6.72
Adjust the numbers as you wish, this is a price predicting model based on sales.
There is NOTHING wrong with the share structure other then widely held false beliefs.
CLUE: NHS average user is predicted to use 10.8 Actipatches a year.
Just 100,000 users is 1,080,000 Actipatches purchased per year.
NHS is the Government of the U.K. which is PAYING for Actipatches for their
Estimated 25-29 Million pain sufferers.
(0)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼